The removal of uremic toxins

被引:116
作者
Dhondt, A [1 ]
Vanholder, R [1 ]
Van Biesen, W [1 ]
Lameire, N [1 ]
机构
[1] Ghent Univ Hosp, Div Renal, Dept Med, B-9000 Ghent, Belgium
关键词
hemodialysis; peritoneal dialysis; CAPD; dialysis efficiency; body fluid toxicity; renal disease;
D O I
10.1046/j.1523-1755.2000.07606.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Three major groups of uremic solutes can be characterized: the small water-soluble compounds, the middle molecules, and the protein-bound compounds. Whereas small water-soluble compounds are quite easily removed by conventional hemodialysis, this is not the case for many other molecules with different physicochemical characteristics. Continuous ambulatory peritoneal dialysis (CAPD) is often characterized by better removal of those compounds. Urea and creatinine are small water-soluble compounds and the most current markers of retention and removal, but they do not exert much toxicity. This is also the case for many other small water-soluble compounds. Removal pattern by dialysis of urea and creatinine is markedly different from that of many other uremic solutes with proven toxicity. Whereas middle molecules are removed better by dialyzers containing membranes with a larger pore size, it is not clear whether this removal is sufficient to prevent the related complications. Larger pore size has virtually no effect on the removal of protein-bound toxins. Therefore, at present, the current dialytic methods do not offer many possibilities to remove protein-bound compounds. Nutritional and environmental factors as well as the residual renal function may influence the concentration of uremic toxins in the body fluids.
引用
收藏
页码:S47 / S59
页数:13
相关论文
共 163 条
[1]  
Abreo K, 1997, J AM SOC NEPHROL, V8, P935
[2]   CUTANEOUS OXALOSIS AFTER LONG-TERM HEMODIALYSIS [J].
ABUELO, JG ;
SCHWARTZ, ST ;
REGINATO, AJ .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (07) :1517-1520
[3]  
AMANN K, 1994, J AM SOC NEPHROL, V4, P1814
[4]   Pennyroyal toxicity: Measurement of toxic metabolite levels in two cases and review of the literature [J].
Anderson, IB ;
Mullen, WH ;
Meeker, JE ;
KhojastehBakht, SC ;
Oishi, S ;
Nelson, SD ;
Blanc, PD .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (08) :726-+
[5]  
Anderstam B, 1996, J AM SOC NEPHROL, V7, P2453
[6]  
Anderstam B, 1997, J AM SOC NEPHROL, V8, P1437
[7]   IDENTIFICATION OF A LOW-MOLECULAR-WEIGHT INHIBITOR OF OSTEOBLAST MITOGENESIS IN UREMIC PLASMA [J].
ANDRESS, DL ;
HOWARD, GA ;
BIRNBAUM, RS .
KIDNEY INTERNATIONAL, 1991, 39 (05) :942-945
[8]   DEPRESSED NATURAL-KILLER CELL-ACTIVITY IN UREMIA - EVIDENCE FOR IMMUNOSUPPRESSIVE FACTOR IN UREMIC SERA [J].
ASAKA, M ;
IIDA, H ;
IZUMINO, K ;
SASAYAMA, S .
NEPHRON, 1988, 49 (04) :291-295
[9]  
BABB AL, 1975, KIDNEY INT, V7, pS23
[10]   CHRONIC BLOCKADE OF NITRIC-OXIDE SYNTHESIS IN THE RAT PRODUCES SYSTEMIC HYPERTENSION AND GLOMERULAR DAMAGE [J].
BAYLIS, C ;
MITRUKA, B ;
DENG, A .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :278-281